Nivolumab-induced cold agglutinin syndrome successfully treated with rituximab.

Hasanov, Merve; Konoplev, Sergej N; Hernandez, Cristhiam M Rojas

Hasanov, Merve; Konoplev, Sergej N; Hernandez, Cristhiam M Rojas.

Affiliation

Hasanov M; Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX; and.
Konoplev SN; Department of Hematopathology and.
Hernandez CMR; Section of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Blood Adv ; 2(15): 1865-1868, 2018 08 14.

Article in En | MEDLINE | ID: mdl-30072374

Subject(s)

Anemia, Hemolytic, Autoimmune/chemically induced; Anemia, Hemolytic, Autoimmune/drug therapy; Anemia, Hemolytic, Autoimmune/pathology; Nivolumab/adverse effects; Rituximab/administration & dosage; Aged, 80 and over; Breast Neoplasms/drug therapy; Breast Neoplasms/pathology; Carboplatin/administration & dosage; Carboplatin/adverse effects; Deoxycytidine/administration & dosage; Deoxycytidine/adverse effects; Deoxycytidine/analogs & derivatives; Female; Humans; Lymphoma, B-Cell, Marginal Zone/drug therapy; Lymphoma, B-Cell, Marginal Zone/pathology; Neoplasms, Second Primary/chemically induced; Neoplasms, Second Primary/drug therapy; Neoplasms, Second Primary/pathology; Nivolumab/administration & dosage; Syndrome; Gemcitabine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rituximab / Nivolumab / Anemia, Hemolytic, Autoimmune Limits: Aged80 / Female / Humans Language: En Journal: Blood Adv Year: 2018 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google